Scandinavian ChemoTech AB Series B (CMOTEC-B) — Working Capital to Net Assets Ratio
Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Working Capital to Net Assets ratio of 31.6% as of September 2025. Working capital of Skr1.96 Million (current assets of Skr13.14 Million minus current liabilities of Skr11.18 Million) is measured against net assets of Skr6.19 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CMOTEC-B net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Scandinavian ChemoTech AB Series B Working Capital to Net Assets (2014–2024)
This chart shows how Scandinavian ChemoTech AB Series B's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 31.6%, reflecting working capital of Skr1.96 Million against net assets of Skr6.19 Million SEK. Check CMOTEC-B tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Scandinavian ChemoTech AB Series B (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Scandinavian ChemoTech AB Series B from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see CMOTEC-B stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 6.2% | Skr370.00K | Skr5.98 Million | Skr7.77 Million | Skr7.40 Million | ▼ -24.3 pp |
| 2023 | 30.5% | Skr3.36 Million | Skr11.03 Million | Skr7.20 Million | Skr3.84 Million | ▲ +1.1 pp |
| 2022 | 29.4% | Skr4.11 Million | Skr13.99 Million | Skr11.82 Million | Skr7.71 Million | ▼ -18.9 pp |
| 2021 | 48.3% | Skr11.54 Million | Skr23.92 Million | Skr13.44 Million | Skr1.89 Million | ▲ +76.1 pp |
| 2020 | -27.8% | Skr-2.57 Million | Skr9.24 Million | Skr4.13 Million | Skr6.70 Million | ▼ -6.3 pp |
| 2019 | -21.6% | Skr-2.10 Million | Skr9.73 Million | Skr5.53 Million | Skr7.63 Million | ▼ -52.2 pp |
| 2018 | 30.6% | Skr6.27 Million | Skr20.50 Million | Skr8.29 Million | Skr2.02 Million | ▼ -0.6 pp |
| 2017 | 31.2% | Skr3.21 Million | Skr10.29 Million | Skr5.32 Million | Skr2.11 Million | ▼ -40.3 pp |
| 2016 | 71.5% | Skr10.43 Million | Skr14.58 Million | Skr12.15 Million | Skr1.72 Million | ▲ +235.9 pp |
| 2015 | -164.4% | Skr-1.43 Million | Skr868.64K | Skr3.61 Million | Skr5.03 Million | ▼ -219.2 pp |
| 2014 | 54.7% | Skr25.33K | Skr46.27K | Skr44.96K | Skr19.63K | — |